# Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

> **NCT00735410** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 134 (actual)

## Conditions studied

- Seasonal Influenza, Vaccine

## Interventions

- **BIOLOGICAL:** Seasonal Influenza Vaccine

## Key facts

- **NCT ID:** NCT00735410
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735410, "Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00735410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*